The integrin αIIbβ3 as an antithrombotic target

This publication has 68 references indexed in Scilit:

• Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay
  Journal of Pharmaceutical and Biomedical Analysis, 1993
• β3 Integrin-Derived Peptide 217-230 Inhibits Fibrinogen Binding and Platelet Aggregation: Significance of RGD Sequences and Fibrinogen Aα-Chain
  Biochemical and Biophysical Research Communications, 1993
• Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
  Stroke, 1992
• Integrins: Versatility, modulation, and signaling in cell adhesion
  Cell, 1992
• Binding of glycoprotein IIIa-derived peptide 217–231 to fibrinogen and von Willebrand factors and its inhibition by platelet glycoprotein IIb/IIIa complex
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
• Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
  Journal of Clinical Investigation, 1988
• Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
  Journal of Clinical Investigation, 1988
• Platelet Activation in Unstable Coronary Disease
  New England Journal of Medicine, 1986
• Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.
  Circulation, 1985
• Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations.
  Circulation, 1982